Vandervoort Adam C's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 3, 2026
- Accession no.
- 0001375088-26-000002
- Filed
- Mar 3, 2026
- Trade date
- Feb 27-Mar 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 7 derivative transactions. Open-market sales total $138.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Vandervoort Adam CCIK 0001375088 | Officer (CHIEF LEGAL OFFICER, SECRETARY) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +4,418 | – | – | 85,150 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +5,350 | – | – | 90,500 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +36,610 | – | – | 127,110 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +1,510 | – | – | 128,620 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseAcquired | +1,702 | – | – | 130,322 | Direct | |
| Mar 2, 2026 | Common Stock | SSaleDisposed | −27,083 | $5.12 | −$138,664.96 | 103,239 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −4,418 | $0.00 | $0 | 0 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −5,350 | $0.00 | $0 | 21,400 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −36,610 | $0.00 | $0 | 73,222 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −1,510 | $0.00 | $0 | 0 | Direct | |
| Feb 27, 2026 | Common Stock | AGrant or awardAcquired | +5,107 | $0.00 | $0 | 5,107 | Direct | |
| Feb 27, 2026 | Common Stock | MOption exerciseDisposed | −1,702 | $0.00 | $0 | 3,405 | Direct | |
| Mar 1, 2026 | Common Stock | AGrant or awardAcquired | +181,661 | $0.00 | $0 | 181,661 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.